← All companies

NBTX

Nanobiotix S.A.

NBTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$38.89

+0.51 +1.32%

Key statistics

from XBRL data in SEC filings

Market cap

$1.88B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$6.90 – $57.14

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 31, 2026 6-K FORM 6-K Jun 5, 2026 6-K FORM 6-K Jun 2, 2026 6-K FORM 6-K Jun 2, 2026 6-K FORM 6-K May 26, 2026 6-K FORM 6-K May 26, 2026 6-K FORM 6-K May 22, 2026 6-K FORM 6-K May 21, 2026 6-K FORM 6-K May 21, 2026 6-K FORM 6-K May 21, 2026 6-K FORM 6-K May 21, 2026 6-K May 20, 2026 6-K FORM 6-K May 18, 2026 6-K FORM 6-K May 5, 2026 6-K FORM 6-K Apr 20, 2026 6-K FORM 6-K Apr 7, 2026 6-K FORM 6-K Mar 31, 2026 20-F Mar 31, 2026 6-K FORM 6-K Mar 30, 2026 6-K FORM 6-K Mar 26, 2026 6-K FORM 6-K Mar 25, 2026 6-K FORM 6-K Mar 12, 2026 6-K FORM 6-K Feb 25, 2026 6-K FORM 6-K Dec 17, 2025 6-K FORM 6-K Dec 15, 2025 6-K Dec 1, 2025 6-K FORM 6-K Nov 24, 2025 6-K FORM 6-K Nov 14, 2025 6-K FORM 6-K Nov 14, 2025 6-K FORM 6-K Nov 12, 2025 6-K FORM 6-K Nov 3, 2025 6-K FORM 6-K Oct 31, 2025 6-K FORM 6-K Oct 24, 2025 6-K FORM 6-K Oct 15, 2025 6-K FORM 6-K Oct 1, 2025 6-K Sep 30, 2025 6-K FORM 6-K Sep 30, 2025 6-K FORM 6-K Sep 30, 2025 6-K FORM 6-K Sep 17, 2025 6-K FORM 6-K Sep 12, 2025